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Background: Microangiopathic brain lesions can be separated in diffuse lesions –
leukoaraiosis – and focal lesions – lacunes. Leukoaraiosis and lacunes are caused by
common cerebrovascular risk factors, but whether they represent a common entity is
not sufﬁciently investigated. The present study aimed to determine the clinical proﬁles
associated with the extent of leukoaraiosis and lacunes. Methods: Sixty-four consecu-
tive patients with acute microangiopathic stroke were studied. Leukoaraiosis and lacunes
were stratiﬁed according to their MRI-based extent. Standardized clinical assessment
included clinical syndromes, cerebrovascular risk factors, cognitive performance, retinal
imaging, ultrasonography, blood, and urine parameters. Results: Different clinical proﬁles
for leukoaraiosis and lacunes were found. Regarding leukoaraiosis, the cognitive scores
(SISCO, mini mental score examination, mental examination) and the presence of hyper-
lipidemia decreased as the severity of leukoaraiosis increased. Univariate and multivariate
analysis revealed that these cognitive score values as well as the presence of hyperlipi-
demia correlated signiﬁcantly with no or only mild leukoaraiosis. Regarding lacunes, the
percentage of migraine, previous stroke events, hydrocephalus, left ventricular hypertro-
phy, and a higher National Institutes of Health Stroke Scale increased as the number
of lacunar lesions increased. Statistical analysis revealed that these parameters corre-
lated not signiﬁcantly with the number of lacunes. Conclusions: The ﬁndings suggests
that leukoaraiosis and lacunes are different microangiopathic entities potentially requiering
different treatment concepts.
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INTRODUCTION
Symptomatic microangiopathic brain lesions (MBL) constitute
about one quarter of all ischemic strokes and are a leading cause
of morbidity and mortality (Lammie, 2002). Morphologically, dif-
fuse affection of cerebral white matter, i.e., – leukoaraiosis – and
focal lesions – lacunes – are distinguished (Barkhof and Scheltens,
2002; Pantoni et al., 2002; Pantoni, 2010).
Previous population-based studies investigated a variety of
clinical factors in the context of MBL. These were associated
with arterial hypertension, diabetes mellitus, and hyperlipidemia
(Hachinski et al., 1987; Sander et al., 2000; Wong et al., 2002). It
is generally assumed that leukoaraiosis and lacunar lesions share
common risk factors. However, few studies have conducted a clin-
ical proﬁle analysis of the two entities in a single study design (Kim
et al., 2011).
The present study aimed to determine differences in the
clinical proﬁle between leukoaraiosis and lacunar lesions. In
microangiopathic strokepatients, the associations and coincidence
of speciﬁc clinical parameters regarding the extent of MBL were
investigated.
MATERIALS AND METHODS
STUDY POPULATION
Consecutive patients with microangiopathic stroke who were
admitted to our stroke unit during a 6-months recruiting period
were prospectively enrolled. Inclusion criteria was a clinically
deﬁned lacunar syndrome according to published criteria (Fisher,
1965; Mohr and Marti-Vilalta, 1998). Exclusion criteria were cor-
tical symptoms, hemorrhagic stroke, or large vessel stroke. The
study was approved by the local ethics committee.
MRI SCANNING
The MRI protocol comprised T2 weighted images, T2*-weighted
images, diffusion-weighted images, and dark ﬂuid sequences
(Siemens 5; 1.5 T) in 6mm slices from the vertex to the fora-
men magnum. Images were evaluated by two independent blinded
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observers (a senior neuroradiologist and an experienced stroke
neurologist).
MICROANGIOPATHIC BRAIN LESIONS
Leukoaraiosis was deﬁned according to published criteria (Pantoni
et al., 2002; Pantoni, 2010). Subjects with discrete leukoaraio-
sis were not considered to be affected (Hachinski et al., 1987;
Barkhof and Scheltens, 2002; Pantoni et al., 2002). The extent of
leukoaraiosis was divided into mild,moderate, and severe changes
(Blennow et al., 1991; Pantoni et al., 2002). Lacunar lesions were
deﬁned as lesions with a diameter of 6–15mm in typical loca-
tions. The number of lacunar lesions was classiﬁed into single,
two to ﬁve and more than ﬁve lacunar lesions (Wahlund et al.,
2001).
CEREBROVASCULAR RISK FACTORS
Diagnostic work up included a standardized questionnaire eval-
uating history of cardiovascular diseases including myocardial
infarction (MI), coronary artery disease (CAD), previous stroke,
and family history. On admission, the leading clinical symptoms,
the National Institutes of Health Stroke Scale (NIHSS), Rankin
Scale (RS), and Barthel Index (BI) were documented. All other
clinical data were recorded 7 days after the acute stroke event.Arte-
rial hypertension was deﬁned by either repeated elevated systolic
blood pressure>160 and/or diastolic blood pressure>95 (Carter,
2004) or the previous use of antihypertensive drugs. Diabetes
was deﬁned by either HbA1c ≥6% or use of antidiabetics (Peters
et al., 1996). Hyperlipidemia was deﬁned either by total cholesterol
≥6.5mmol/l, triglycerides ≥2.3,HDL cholesterol ≤1.0mmol/l, or
use of lipid-lowering drugs. Proteinuria was deﬁned as urinary
albumin>20mg/dl. Renal insufﬁciency was deﬁned as serum cre-
atinine >120μmol/l. Patients who did not currently smoke were
divided in non-smokers and past smokers (≥5 years). Current
smokers were evaluated in pack years (py). Alcohol consump-
tion was stratiﬁed into g alcohol/month (Vriz et al., 1998). Body
mass index (BMI, kg/m2) was calculated from height and weight
measurements.
COGNITIVE FUNCTIONS
Cognitive functions were assessed by the SIDAM score SISCO
(Structured Interview for the Diagnosis of Dementia of the
Alzheimer Type, multi-infarct dementia, and dementias of other
etiology according to DSM-III-R and ICD-10) including the
SIDAM Mini Mental Score Examination (MMSE) and mental
examination (ME; Zaudig, 1992). In addition, the Beck Depression
Inventory was performed (Beck et al., 1961).
RETINAL IMAGING
Retinal imaging to evaluate hypertensive retinopathy was per-
formed after 5min dark adaptation in mydriatic pupils. An oph-
thalmologist who was unaware of the clinical data evaluated the
retinal imaging according to a standardized protocol. Hyper-
tensive retinopathy was classiﬁed in mild, moderate, and severe
retinopathy (Wong et al., 2002; Wong, 2004).
VASCULAR ULTRASONOGRAPHY
The pulsatility index (PI) of the MCA was recorded with a Doppler
device (Multi-Dop X4,DWL) with the PI calculated automatically.
Intima-media-thickness of the common carotid artery was deﬁned
by duplex sonography according to the method described by
Simons et al. (1999).
ELECTROCARDIOGRAPHY
Left ventricular hypertrophy (LVH) was identiﬁed by the gen-
der speciﬁc Cornell voltage-duration product (RaVL+ SVIII)×
QRS> 2440mm·ms in men and (RaVL+ SVIII + 8mm)×QRS>
2440mm·ms in women. An additional acceptance criterion was
based on thenon-gender-speciﬁc Sokolow–Lyon voltage combina-
tion (SV1 +RV5 or RV6)> 38mm (Dahlof et al., 1998). Atrial ﬁb-
rillation was also deﬁned by either conventional electrocardiogram
or history of atrial ﬁbrillation.
DATA ANALYSIS
Data were presented as mean± SD for continuous variables and
as proportions for categorical variables. Exploratory data analy-
sis was performed to explore possible associations and to gen-
erate hypotheses. Due to the small number of patients, unad-
justed p-values from Fisher’s exact tests are reported only to give
a hint on possible associations. Due to the small sample size,
variables leukoaraiosis and lacunar lesions were dichotomized
to at least ensure useful group sizes for group comparisons:
leukoaraiosis was dichotomized by either non or only mild
changes on MRI, or moderate to severe leukoaraiosis and lacunes
were dichotomized by either no or one lacunar lesion, or ≥2
lacunes.
RESULTS
Sixty-four patients (25 female, 35 male, mean age of
65.5± 10.8 years) were investigated. Baseline characteristics of the
study population are given in the Table 1.
LEUKOARAIOSIS
Using four groups (no, mild, moderate, and severe leukoaraio-
sis) for evaluation of mean values, we observed that the cognitive
scores SISCO,ME, and MMSE as well as the percentage of patients
with hyperlipidemia decreased as the severity of leukoaraiosis
increased. Using two groups (non or mild leukoaraiosis versus
moderate or severe leukoaraiosis) for statistical analysis, Fisher’s
exact test revealed that the cognitive score values for ME, MME,
and SISCO above median correlated signiﬁcantly with no or mild
leukoaraiosis. The same was found for the percentage of patients
with hyperlipidemia.
Due to the small sample size using multivariable methods
is a problematical issue. To inspect the joint inﬂuence of the
risk factors detected by univariate analysis on the probability
for at least moderate leukoaraiosis and to adjust for age, small
logistic regression models were selected and ﬁtted correspond-
ing to the following criteria: as few as possible missing observa-
tions, signiﬁcant exploratory variables, goodness of ﬁt (calibration,
Hosmer–Lemeshow-Test), usefulness at prediction of outcome
(Nagelkerke R2), and ability for discrimination (AUCROC). Only
models with age and two additional exploratory variables were
incorporated. With the caveat of small sample size and there-
fore purely empirical selection of models there were two “best”
selected models which roughly complied with the criteria above
(Table 2).
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Table 1 | Clinical parameters in regard to the extent of cerebral microangiopathy.
Parameter (n) Leukoaraiosis Leukoaraiosis Lacunes Lacunes
No+mild (48) Moderate+ severe (16) 0+1 (14) 2–5+>5 (50)
Mean age (years),±SD 63±11 68±9 65±9 64±11
Lacunar lesions,% (n) 83 (40) 100 (16)
Leukoaraiosis,% (n) 57 (8) 82 (41)
SISCO, mean±SD 50±4 44±9 49±5 48±7
MME, mean±SD 28±2 26±4 28±2 28±3
ME, mean±SD 17±3 13±3 16±3 16±3
Hyperlipidemia (history),% (n) 54 (26) 19 (3) 64 (9) 40 (20)
Hyperlipidemia (measurements)% (n) 71 (34) 56 (9) 71 (10) 66 (33)
Migraine,% (n) 29 (14) 38 (6) 14 (2) 36 (18)
Previous stroke (history),% (n) 25 (12) 56 (9) 7 (1) 40 (20)
Previous stroke (imaging),% (n) 75 (36) 100 (16) 14 (2) 100 (50)
Left ventricular hypertophy,% (n) 6 (3) 6 (1) 0 (0) 8 (4)
Hydrocephalus,% (n) 2 (1) 19 (3) 0 (0) 8 (4)
NIHSS, mean±SD 3.4±1.8 3.8±2.0 3.0±2.3 3.6±1.7
Barthel index, mean±SD 92.5±17.8 89.7± 22.3 91.8±25.2 91.8±17.1
Rankin scale, mean±SD 2.2±1.2 2.3±1.3 2.1±1.2 2.2±1.2
Retinopathy,% (n) 48 (23) 75 (12) 43 (6) 58 (29)
Hypertension (history),% (n) 71 (34) 69 (11) 86 (12) 66 (33)
Hypertension (measurements),% (n) 73 (35) 75 (12) 86(12) 70 (35)
Diabetes (history),% (n) 29 (14) 31 (5) 21 (3) 32 (16)
Diabetes (measurements),% (n) 40 (19) 50 (8) 36 (5) 44 (22)
Pack years, mean±SD 22±31 9±11 13±17 21±30
Current smoking, n (%) 38 (18) 31 (5) 21 (3) 40 (20)
Alcohol (g/month), mean±SD 259±532 154±354 229±449 299±509
BMI, mean±SD 27±5 26±4 27±5 27±4
Atrial ﬁbrillation,% (n) 13 (6) 13 (2) 21 (3) 10 (5)
Foramen ovale,% (n) 13 (6) 6 (1) 14 (2) 10 (5)
Pulsatility index, mean±SD 1.06±0.20 1.15±0.19 1.03±0.13 1.10±0.21
Intima-media thickness, mean±SD 0.08±0.02 0.08±0.01 0.08±0.02 0.10±0.01
Proteinuria,% (n) 15 (7) 6 (1) 7 (1) 14 (7)
Emotional incontinence,% (n) 6 (3) 19 (3) 14 (2) 8 (4)
BDI, mean±SD 8±6 10±7 7±5 8±6
LACUNAR LESIONS
Using four groups (no, single, two to ﬁve, and >5 lacunar lesion)
for evaluation of mean values, the percentage of migraine, pre-
vious stroke events, hydrocephalus, LVH, and a higher NIHSS
increased as the number of lacunar lesions increased. Using two
groups (no or one lacunar lesion versus ≥2 lacunar lesions)
for statistical analysis, univariate analysis (for continuous vari-
ables: Man–Whitney test; for categorical variables: Fisher’s exact
test) revealed no signiﬁcantly associated clinical parameters even
at signiﬁcance level 0.10. Therefore in view of only 14 patients
with less then two lacunar lesions multivariate analysis was not
performed.
DISCUSSION
The pathogenesis of MBL is poorly understood. It remains unclear
why some patients develop isolated lacunes while other patients
also develop leukoaraiosis (Hassan et al., 2003). Hypertension
is a major risk factor but fails to account for much of the risk
(Boiten et al., 1993; Hassan et al., 2003). Imaging and autopsy-
based studies propose two types of MBL. They separate patients
with single lacunes without leukoaraiosis, a microatheromatous
disease of larger perforating arteries, and the usual vascular risk
factors versus patients with multiple lacunes and leukoaraiosis,
diffuse arteriosclerosis of smaller perforating arteries, and a high
frequency of hypertension (Fisher, 1969; Boiten et al., 1993; Khan
et al., 2007).
Only few studies analyzed the two entities of MBL in a single
study design. The present study investigated a variety of clini-
cal parameters with regard to the extent of leukoaraiosis and
lacunes. The study results demonstrated evidence for different
clinical proﬁles in leukoaraiosis and lacunes, respectively.
The most reliable parameter regarding the severity of
leukoaraiosis was the cognitive performance measured with the
SIDAM including the SISCO, MMSE, and ME. The SIDAM
test covers a broad range of cognitive functions for diagnosis
of even mild cognitive impairment (Zaudig, 1992). Even the
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Table 2 | Statistical analysis (dichotomization in no leukoaraiosis+
mild leukoaraiosis versus moderate leukoaraiosis+ severe
leukoaraiosis).
UNIVARIATE ANALYSIS, ME, SISCO, AND MMS DICHOTOMIZED
ACCORDINGTO SAMPLE MEDIAN
Original variable Median p-Value$ OR 95% CI for OR
ME 16 <0.0005 0.05 (0.01, 0.38)
SISCO 50 0.001 0.05 (0.01, 0.41)
MMS 28 0.008 0.16 (0.04, 0.65)
Hyperlipidemia 0.020 0.19 (0.05, 0.77)
MULTIVARIATEANALYSIS USING FORWARD SELECTION
(WALD-TEST)
Variable p-Value wald-test OR 95% CI OR
Model 1
Age 0.500 0.97 (0.90, 1.05)
ME 0.005 0.03 (0.003, 0.36)
Hyperlipidemia 0.030 0.17 (0.03, 0.84)
Model 2
Age 0.439 0.97 (0.90, 1.05)
SISCO 0.003 0.02 (0.002, 0.28)
Hyperlipidemia 0.007 0.10 (0.02, 0.52)
$p-Values from Fisher’s exact test.
CI, Conﬁdence Interval; OR, Odds Ratio.
subitems MMSE and ME were sufﬁcient to indicate at least
moderate leukoaraiosis. Consistently, other MRI-based studies
found that the extent of leukoaraiosis is strongly correlated with
cognitive performance (Merino, 2008) and that the progression
of leukoaraiosis is associated with progression in cognitive decline
(Dijk et al., 2008). Interestingly, the presence of hyperlipidemia
was a negative indicator of leukoaraiosis. Some authors suggest a
protective role of hyperlipidemia against cerebral small-vessel dis-
ease (Warsch and Wright, 2010). Since 96% of our patients with
known hyperlipidemia used statins, pharmacological effects have
also to be considered.
Regarding the extent of lacunes, a higher NIHSS, previous
stroke events, andLVHweremorepresent in patientswithmultiple
lacunes, but no statistical signiﬁcance was found. Interestingly,
the presence of migraine was higher in patients with multiple
lacunes. Migraine is a leading clinical feature in some mono-
genetic small-vessel diseases such CADASIL or HERNS (Dichgans
et al., 1998; Kruit et al., 2004). The etiology of MBL associated
with migraine is unknown (Kruit et al., 2004). Spreading depo-
larizations are assumed to be the pathophysiological correlate of
the migraine (Moskowitz, 2007). Small-vessel disease of the brain
likely causes recurrent small perfusion deﬁcits that might give rise
to spreading depolarizations and migraine, consecutively (Dreier
et al., 2002).
Arterial hypertension and older age were found in the vast
majority of patients with leukoaraiosis and lacunes, as shown in
other studies (de Leeuw et al., 2002). This validates arterial hyper-
tension as an important risk factor for leukoaraiosis and lacunar
lesions (Bryan et al., 1997; Lee et al., 2000). However, a correlation
with the severity of MBL was not found. 25% of the study cohort
had no hypertension, indicating that MBL are not synonymous
with hypertensive microangiopathy.
The limiting factor of the present study is the small number
of patients due to the intraindividually extraordinary expense
for conducting a broad and general investigation. Follow up
studies have to conﬁrm the assumption of different microangio-
pathic entities. As a drawback of the MR protocol- the smallest
lacunar lesions with a diameter of 5–6mm might have been
missed.
In conclusion, only few studies separately investigated
leukoaraiosis and lacunar lesions. The present study found dif-
ferent clinical proﬁles of patients with leukoaraiosis and lacunes.
This suggests that the pathophysiological process is likely to differ
and different treatment concepts may be required (Khan et al.,
2007).
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